AGP Picks
View all

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on August 7, 2026

TheGenieLab Expands AI Rewrite App to Cover Shopify Articles, Pages and Products
Beyond Encouragement: Momcozy Calls for Breastfeeding Support That Works in Real Life
China Intramedullary Nails Manufacturers for Vietnam’s Long-Bone Fracture Treatment Market
Nova Leap Health Corp. Posts Record Q2 2026 Revenue, Income from Operating Activities and Adjusted EBITDA
my mimi Named Best Menstrual Disc in Australia for 2026
Citizens Commission on Human Rights International Urges U.S. Action After U.N. Committee Condemns Forced Psychiatric Detention and Treatment
SodaTide Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Spyre Therapeutics Announces Grants of Inducement Awards
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entera Announces Second Quarter 2026 Financial Results and Business Updates
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Amwell makes grant to new employees under inducement plan
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.